Through a pioneering initiative called Chronos-PD, Grifols is partnering with the Michael J. Fox Foundation for Parkinson’s ...

Two of the first patients of adaptive Deep Brain Sitimulation (aDBS) Parkinson’s therapy and the neurologist who developed ...

Existing research indicates that the accuracy of a Parkinson’s disease diagnosis hovers between 55% and 78% in the first five years of assessment. That’s partly because Parkinson’s sibling movement ...

Steve heads to the Hackensack Meridian Count Basie Theatre in Red Bank, New Jersey on Friday, Sept. 19, 2025. Then he packs ...

Gloria Palacios Mattick was a loving wife, an amazing mother, a caring daughter, sister, and aunt, and a wonderful friend to ...

From upcycled plastic trash to job placement for Palestinian workers, secondhand e-commerce to simplified charitable giving, ...

- Glyoxalase Domain-containing Protein 4 (GLOD4), the First Identified in a New Class of Enzymes Called Nitrases, Generates ...

A St. Louis-based company known for its work in Alzheimer's and neurological testing can expand its footprint, thanks to a $10 million investment from several life sciences companies.

Interim Analysis Expected End of 2Q 2025BETHESDA, MD, Mar 14, 2025 - (ACN Newswire) - Gain Therapeutics, Inc. (Nasdaq: GANX) ...

Across two cohorts, the Automated Imaging Differentiation for Parkinsonism (AIDP) machine learning model distinguished ...

Parkinson’s disease cases could double, reaching over 25 million worldwide. A new study reveals that aging and population ...

Gus Swoboda passed away peacefully with his family by his side on Friday, March 14, 2025. We will miss him, but we will find ...